All In MedTech

FDA Clearance Tracker · P100030-S008

PreveLeak Surgical Sealant

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 21, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 21, 2017

Approved

Time to decision

171 days

Received Jul 3, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P100030-S008
Device name
PreveLeak Surgical Sealant
Applicant location
Deerfield Lake, IL
Received
Jul 3, 2017
Decided
Dec 21, 2017
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P100030

Device type

Device class
Class III

Every decision under product code NBE

FDA's approval statement

As written in FDA's record.

Approval for Preveleak Surgical Sealant. The device is indicated for use in vascular and cardiac reconstructions (excluding application to arterial and venous grafts used in coronary artery bypass graft surgery) to achieve adjunctive hemostasis by mechanically sealing areas of potential leakage.

Source documents

Other decisions for Baxter Healthcare Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.